Popp, Oliver <br/><br/>
The calpastatin-derived calpain inhibitor CP1B reduces mRNA expression of matrix metalloproteinase-2 and -9 and invasion by leukemic THP-1 cells.  [electronic resource] 

 -  Biological chemistry  Jun 2003 
 - 951-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1431-6730 
<br/><br/><label>Standard No.: </label>10.1515/BC.2003.107  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Calcium-Binding Proteins--metabolism<br/>Cell Division--drug effects<br/>Cell Survival--drug effects<br/>Extracellular Matrix--metabolism<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Glycoproteins--metabolism<br/>Humans<br/>Leukemia--drug therapy<br/>Matrix Metalloproteinase 2--genetics<br/>Matrix Metalloproteinase 9--genetics<br/>Neoplasm Invasiveness<br/>RNA, Messenger--genetics<br/>Tumor Cells, Cultured